Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes.

Abstract

INTRODUCTION:

The co-association of benzodiazepines and opioids is associated with an increased risk of overdose, death, and poorer psychosocial prognosis. The aim of this study is to characterize the prevalence, pattern of use, and primary clinical outcomes in benzodiazepines users in a public opioid maintenance treatment unit.

MATERIAL AND METHODS:

We conducted a cross-sectional study involving 236 patients treated with opioid substitutes (methadone and buprenorphine). We conducted a descriptive, bivariable, and multivariable analysis to determine clinical differences between benzodiazepines users and non-users.

RESULTS:

The prevalence of consumption of benzodiazepines was 25.4% (60). The benzodiazepines were obtained with a medical prescription (49.8%) or on the black market (42.6%). The most prescribed benzodiazepine was diazepam (29.1%), and the main reasons were to relieve insomnia (27.7%) or anxiety (26.9%) and to enhance the psychoactive effects of other drugs (19.7%). Regarding the clinical outcomes, we highlight: a very high prevalence of hepatitis C (51.7%); severe ongoing consumption of psychoactive drugs (73.7%); and a high rate of depression and anxiety (> 60%), significantly higher in the benzodiazepines-user group. In the multivariable analysis of benzodiazepine use, we found alcohol consumption (OR 0.482; IC 95% 0.247, 0.238) had a negative association and having hepatitis C (OR 2.544, IC 95% 1.273, 5.084) or anxiety symptoms (OR 5.591; IC 95% 2.345, 13.326) had positive associations.

DISCUSSION:

Our results suggest the BZD users had a complex drug addiction problem and underline the importance of adequately addressing BZD use, contemplating psychological and psychiatric approach in this particular population.

CONCLUSION:

Past or current use of benzodiazepines is associated with poor clinical and psychiatric outcomes. A multidisciplinary approach with a focus on infectious diseases and mental health is critical in order to enhance the treatment effectiveness and overall prognosis.

• Authors: Catarina Oliveira, Rita Filipe, João Meira, Lara Sampaio, Leonor Teixeira, Júlio Rodrigues, Inês Nunes, João Tavares
• Journal: Acta medica portuguesa (Acta Med Port) Vol. 34 Issue 3 Pg. 209-216 (Mar 01 2021) ISSN: 1646-0758 [Electronic] Portugal
• PMID: 33971116 (Publication Type: Journal Article)

Chemical References

• Analgesics, Opioid
• Narcotics
• Benzodiazepines
• Buprenorphine
• Diazepam
• Methadone

Topics

• Adult
• Analgesics, Opioid (therapeutic use)
• Anxiety (epidemiology, rehabilitation)
• Benzodiazepines (therapeutic use)
• Buprenorphine (adverse effects, therapeutic use)
• Cross-Sectional Studies
• Diazepam (adverse effects, therapeutic use)
• Female
• Humans
• Male
• Mental Disorders (epidemiology, rehabilitation)
• Methadone (adverse effects, therapeutic use)
• Middle Aged
• Narcotics (therapeutic use)
• Opiate Substitution Treatment
• Opioid-Related Disorders (epidemiology, psychology, rehabilitation)
• Portugal (epidemiology)
• Prevalence
• Sleep Initiation and Maintenance Disorders (epidemiology, rehabilitation)
• Surveys and Questionnaires
• Treatment Outcome